Navigation Links
Anticancer Drugs Targeting the ErbB (EGFr/HEr2) Pathway Alone Generated Global Sales of Nearly $5 Billion in the First Nine Months of 2007
Date:11/27/2007

Currently, Over 370 Agents are in Active Clinical Development, Addressing

Over 190 Targets

LAKE FOREST, Calif., Nov. 27 /PRNewswire/ -- Six ErbB (EGFr/HEr2)-pathway inhibitors, marketed for the treatment of several major solid tumor indications, generated global sales of $4,964.4 million in the first 9 months of 2007, almost surpassing the $5,160 million total revenues of these agents in 2006.

Despite this unprecedented market success and the acceptance of targeted therapies in oncology practice, many challenges remain unfulfilled. One key problem of currently approved agents is the relatively marginal benefits they provide; median progression-free survival (PFS) and overall survival (OS) are extended only by a few months. However, aggressive efforts to overcome current limitations are providing unique opportunities in this field.

Currently, all targeted therapeutics, both approved and novel are under evaluation almost exclusively in combination with approved cytotoxic agents. Because cytotoxics remain the treatment mainstay for adjuvant, neoadjuvant and advanced/metastatic disease, opportunities still exist for the development of more effective, less toxic alternatives.

Targeted therapeutics are also under investigation in combination with each other, in efforts to simultaneously inhibit additional or compensating pathways, or to maximize effectiveness against a single target by combining drugs acting by different mechanisms, e.g., receptor tyrosine kinase (RTK) inhibitors and monoclonal antibodies (MAb), against the same target. Also, multitargeted inhibitors are in development against different targets in the same or different pathways hypothesized to act in concert in malignancy.

The commercial success of the ErbB inhibitors and other targeted anticancer agents has stimulated R&D in this field. More than 370 drugs have entered clinical trials, with many having already reached phase II (n=183)
'/>"/>

SOURCE New Medicine's Oncology KnowledgeBASE
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. New review suggests caution on drugs to raise good cholesterol
2. Can cancer drugs combine forces?
3. Study provides hope that some transplant patients could live free of antirejection drugs
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
5. RA Drugs Linked to Slight Skin Cancer Risk
6. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
7. Rock N Roll: Sex, Drugs and an Early Exit
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Study suggests brain tumors need treatment with multiple targeted drugs
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 Today, Zane Benefits, ... Reimbursement Accounts . Zane Benefits, which provides comprehensive and ... the leader in defined contribution and ... Benefits’ website, employees of a company who sets up ... questions about how Health Reimbursement Accounts work. Educating employees ...
(Date:6/18/2013)... New York, NY (PRWEB) June 18, 2013 ... Sinai Medical Center to its “Best Doctors” list, up ... in New York City. The new issue also lists 52 ... network, which continues on a strategic growth trajectory. The “Best ... physicians, appears in the June 24 print issue and is ...
(Date:6/18/2013)... Local chemical signals released by fat cells in the ... exposure to unrelenting social stressors early in life, and ... University of Chicago report in the July 2013 issue ... Some forms of stress exposure may be associated with ... cancer. But the mechanisms linking the biology of social ...
(Date:6/18/2013)... June as Lesbian, Gay, Bisexual and Transgender ... civil rights, sexual minority youth are still ... heterosexual peers, according to the Suicide Prevention ... graduate student recently published recommendation to improve ... could help improve psychological functioning and reduce ...
(Date:6/18/2013)... 2013)-- An international team of investigators co-led by Weill ... evidence-based surgery and device research, similar to the kind ... , "Currently, there is no dynamic research framework to ... benefits to patients or may even be harmful," says ... College. , In the June 18 issue of ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4Health News:Sexual minority youth need specialized treatment from therapists 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3
... published in the Journal of Vascular Surgery reported that ... better// when accompanied by a suction device to remove ... kidneys. ,Researchers from the Wake Forest University ... that short, less invasive procedures restored enough blood flow ...
... now investigating Dr Wakefield over claims of serious professional misconduct//. ... Wakefield and subsequently published in The Lancet in 1998, had ... might exist a causal link between the combined measles, mumps ... ,Reports now indicate that the GMC is now charging ...
... The death of a 65-year-old woman at the ... Ms Hannah Comber died //from asphyxiation after she ... special chair.,The HSE said, it is fully co-operating ... into the incident at a continuing care facility ...
... have found that astemizole, which is used for treating ... for treating malaria//. ,According to a study conducted ... Public Health and the Johns Hopkins University School of ... Malaria Research Institute (MRI), determined that in a test ...
... the urology segment, pharma major Dr Reddys Laboratories Ltd ... release tablets of 10 mg dosage. ... indicated for treatment of enlargement of prostate gland in ... company release said., ,The product was launched nationwide, ...
... volunteers have found that external ‘condom’ catheter showed lesser ... ,An 80 per cent reduction in urinary ... was collected with condom type catheter, which proved a ... ,In fact, men whose urine was collected with an ...
Cached Medicine News:Health News:Blood Flow to Kidneys Better Restored by Less Invasive Procedures 2Health News:Antihistamine Could also be used as a Potential Antimalarial Drug 2Health News:External Catheters Linked with decreased UTI Risk in Men 2Health News:External Catheters Linked with decreased UTI Risk in Men 3Health News:External Catheters Linked with decreased UTI Risk in Men 4
(Date:6/18/2013)... June 18, 2013  Millennium HealthCare Inc. (OTC ... into an exclusive 25-year Supply and Distribution agreement ... Corporation ("EWC") for its Distance Monitored Physical Therapy ... physical therapy program is a critical element in ... said Chris Amandola , president, Millennium HealthCare ...
(Date:6/18/2013)... , June 18, 2013  Specialty ... significant breakthrough in Parylene coating technologies: SCS ... the benefits of Parylene with antimicrobial properties ... devices and components. (Logo: ... infections (HAIs) increase and continue to pose ...
(Date:6/18/2013)... MPR is excited to unveil a new logo and ... of an ongoing effort to freshen the look and feel ... years. (Photo: http://photos.prnewswire.com/prnh/20130618/NY33937 ) ... has expanded upon its foundation as a concise drug information ... array of clinical and practice management tools including a cloud-based ...
Breaking Medicine Technology:Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 2Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 3Specialty Coating Systems Announces New Antimicrobial Parylene Technology 2MPR Sports a Bold New Look 2
... The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine ... as its July 2010 "Stock to Study" and Gilead ... for investors, informational and educational use. , ... "The committee chose Teva Pharmaceutical Industries because of the tremendous ...
... EAST BRUNSWICK, N.J. , April 30 Savient Pharmaceuticals, Inc. (Nasdaq: ... the first quarter 2010 following the close of the market on Wednesday ... , ... Financial Officer, will host an investment community conference call beginning at 10:00 ...
Cached Medicine Technology:BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 2BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 3Savient Pharmaceuticals To Hold First Quarter 2010 Results 2
... the quantitative determination of Erythropoietin (EPO) in human ... diagnostic use, as an aid in the diagnosis ... the administration of recombinant erythropoietin as a biologic ... erythropoietin assay may be used also to aid ...
... The innovative PoleStar N20, exclusively ... for intra-operative MRI. Combining intra-operative ... completely registration-free system, PoleStar N20 is ... tools available today. , , Exceptional ...
... PREMIUM SURGICLIP II™ single use ... Super Interlock™ clips., ,The ... applier has application in many ... occlude vessels and other tubular ...
... Powered LDS™ single use stapler places two ... cartridge jaw and a knife which divides ... , ,The Auto Suture™ Powered LDS™ ... application in abdominal, gynecological, orthopedic, and thoracic ...
Medicine Products: